Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock
Arjun Agarwal, Vice President of Finance at Oruka Therapeutics, sold 533 shares of the company's stock on September 21, 2026, for a total of $51,034. The sale, carried out under a pre-established trading plan, was documented in a recent regulatory filing. Prior to the sale, Mr. Agarwal owned 14,219 shares of Oruka Therapeutics common stock.
The company's stock price has increased by over 500% in the past year, currently valued at $93.38 with a market capitalization of $6.17 billion. Despite the notable stock performance, Oruka Therapeutics has not reported profitability in the last twelve months. Analysts have provided mixed opinions on the company's prospects, with some maintaining a Buy rating while others express concerns over the company's profitability.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
